Page 1 | Search Results | Hematology, ASH Education Program

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.

https://doi.org/10.1182/asheducation-2018.1.213

Published: 2018

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Cellular immune responses in red blood cell alloimmunization

James C. Zimring, Krystalyn E. Hudson

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 452–456.

https://doi.org/10.1182/asheducation-2016.1.452

Published: 2016

Journal Articles

Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responses

Birgit M. Reipert

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 372–378.

https://doi.org/10.1182/asheducation.V2014.1.372.3884771

Published: 2014

Journal Articles

Hemophagocytic lymphohistiocytosis: pathogenesis and treatment

Gritta E. Janka, Kai Lehmberg

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 605–611.

https://doi.org/10.1182/asheducation-2013.1.605

Published: 2013

Journal Articles

Immunotherapeutic strategies including transplantation: eradication of disease

John G. Gribben, John C. Riches

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 151–157.

https://doi.org/10.1182/asheducation-2013.1.151

Published: 2013

Journal Articles

Immunomodulatory Mediators in Platelet Transfusion Reactions

Craig N. Morrell

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 470–474.

https://doi.org/10.1182/asheducation-2011.1.470

Published: 2011

Journal Articles

Pathobiology of Peripheral T-cell Lymphomas

Elaine S. Jaffe

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 317–322.

https://doi.org/10.1182/asheducation-2006.1.317

Published: 2006

Journal Articles

Pathophysiologic Mechanisms in Acquired Aplastic Anemia

Neal S. Young

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 72–77.

https://doi.org/10.1182/asheducation-2006.1.72

Published: 2006

Journal Articles

Immunobiology and Pathophysiology of Hodgkin Lymphomas

Sibrand Poppema

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 231–238.

https://doi.org/10.1182/asheducation-2005.1.231

Published: 2005

Journal Articles

Familial and Acquired Hemophagocytic Lymphohistiocytosis

Gritta Janka, Udo zur Stadt

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 82–88.

https://doi.org/10.1182/asheducation-2005.1.82

Published: 2005

Journal Articles

Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin Lymphomas

Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 260–266.

https://doi.org/10.1182/asheducation-2005.1.260

Published: 2005

Journal Articles

Immunotherapeutic Approaches for Hematologic Malignancies

Michael A. Caligiuri, Andrea Velardi, David A. Scheinberg, Ivan M. Borrello

Hematology Am Soc Hematol Educ Program (2004) 2004 (1): 337–353.

https://doi.org/10.1182/asheducation-2004.1.337

Published: 2004

Journal Articles

Immunotherapy of Hematologic Malignancy

Helen E. Heslop, Freda K. Stevenson, Jeffrey J. Molldrem

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 331–349.

https://doi.org/10.1182/asheducation-2003.1.331

Published: 2003

Journal Articles

Congenital Bleeding Disorders

Margaret E. Rick, Christopher E. Walsh, Nigel S. Key

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 559–574.

https://doi.org/10.1182/asheducation-2003.1.559

Published: 2003

Journal Articles

Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome

Theodore E. Warkentin, William C. Aird, Jacob H. Rand

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 497–519.

https://doi.org/10.1182/asheducation-2003.1.497

Published: 2003

Journal Articles

Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma

Elizabeth Macintyre, Dennis Willerford, Stephan W. Morris

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 180–204.

https://doi.org/10.1182/asheducation.V2000.1.180.180

Published: 2000

NARROW

Indolent lymphomas: pushing the pace with novel agents

Where does PD-1 blockade fit in HL therapy?

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Graft versus tumor effects and why people relapse

Cellular immune responses in red blood cell alloimmunization

Risky business of inhibitors: HLA haplotypes, gene polymorphisms, and immune responses

Hemophagocytic lymphohistiocytosis: pathogenesis and treatment

Immunotherapeutic strategies including transplantation: eradication of disease

Immunomodulatory Mediators in Platelet Transfusion Reactions

Pathobiology of Peripheral T-cell Lymphomas

Pathophysiologic Mechanisms in Acquired Aplastic Anemia

Immunobiology and Pathophysiology of Hodgkin Lymphomas

Familial and Acquired Hemophagocytic Lymphohistiocytosis

Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin Lymphomas

Immunotherapeutic Approaches for Hematologic Malignancies

Immunotherapy of Hematologic Malignancy

Congenital Bleeding Disorders

Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome

Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only